Top Pharmaceuticals companies in Japan by Price to Sales Ratio (P/S)

This ranking features the top 225 Pharmaceuticals companies in Japan ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 249.34, for January 15, 2025.

Japan

Pharmaceuticals

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	BrightPath Biotherapeutics Co., Ltd. 1 4594.T	48,782.23	Jan. 14, 2025	USD 0.27	-4.62%	Japan
2	FunPep Company Limited 2 4881.T	6,112.67	Jan. 14, 2025	USD 0.87	-0.91%	Japan
3	Oncolys BioPharma Inc. 3 4588.T	163.48	Jan. 14, 2025	USD 3.27	-0.38%	Japan
4	MedRx Co., Ltd 4 4586.T	110.94	Jan. 14, 2025	USD 0.52	1.05%	Japan
5	Kringle Pharma, Inc. 5 4884.T	97.44	Jan. 14, 2025	USD 7.09	6.47%	Japan
6	Perseus Proteomics Inc. 6 4882.T	81.83	Jan. 14, 2025	USD 3.73	-2.66%	Japan
7	NanoCarrier Co., Ltd. 7 4571.T	70.35	Jan. 14, 2025	USD 0.90	-4.23%	Japan
8	Kubota Pharmaceutical Holdings Co., Ltd. 8 4596.T	64.42	Jan. 14, 2025	USD 0.32	-0.18%	Japan
9	Stella Pharma Corporation 9 4888.T	60.23	Jan. 14, 2025	USD 3.22	1.41%	Japan
10	CellSeed Inc. 10 7776.T	59.53	Jan. 14, 2025	USD 2.40	-4.95%	Japan
11	Cyfuse Biomedical K.K. 11 4892.T	52.98	Jan. 14, 2025	USD 2.84	0.26%	Japan
12	Renascience Inc. 12 4889.T	33.36	Jan. 14, 2025	USD 3.43	17.10%	Japan
13	SUSMED,Inc. 13 4263.T	31.32	Jan. 14, 2025	USD 4.01	-3.09%	Japan
14	Tsubota Laboratory Incorporated 14 4890.T	15.09	Jan. 14, 2025	USD 2.58	-1.87%	Japan
15	D. Western Therapeutics Institute, Inc. 15 4576.T	12.35	Jan. 14, 2025	USD 1.00	-3.25%	Japan
16	Solasia Pharma K.K. 16 4597.T	11.34	Jan. 14, 2025	USD 0.22	-5.58%	Japan
17	MEDINET Co., Ltd. 17 2370.T	10.96	Jan. 14, 2025	USD 0.22	-2.96%	Japan
18	OncoTherapy Science, Inc. 18 4564.T	10.23	Jan. 14, 2025	USD 0.15	4.16%	Japan
19	HOYA Corporation 19 7741.T	8.86	Jan. 14, 2025	USD 128.19	-0.84%	Japan
20	Chugai Pharmaceutical Co., Ltd. 20 4519.T	8.84	Jan. 14, 2025	USD 43.03	0.75%	Japan
21	PeptiDream Inc. 21 4587.T	8.69	Jan. 14, 2025	USD 14.50	-2.58%	Japan
22	Japan Tissue Engineering Co., Ltd. 22 7774.T	7.39	Jan. 14, 2025	USD 3.02	0.87%	Japan
23	JMDC Inc. 23 4483.T	7.28	Jan. 14, 2025	USD 23.80	1.60%	Japan
24	Asahi Intecc Co., Ltd. 24 7747.T	6.36	Jan. 14, 2025	USD 15.87	-0.88%	Japan
25	Nxera Pharma Co., Ltd. 25 4565.T	5.86	Jan. 14, 2025	USD 6.14	-1.80%	Japan
26	GNI Group Ltd. 26 2160.T	5.36	Jan. 14, 2025	USD 19.77	1.11%	Japan
27	GLOME Holdings,Inc. 27 8938.T	5.08	Jan. 14, 2025	USD 4.63	3.21%	Japan
28	Immuno-Biological Laboratories Co., Ltd. 28 4570.T	4.96	Jan. 14, 2025	USD 2.90	-2.94%	Japan
29	Cytori Cell Research Institute, Inc. 29 3750.T	4.83	Jan. 14, 2025	USD 5.61	0.04%	Japan
30	Mani, Inc. 30 7730.T	4.72	Jan. 14, 2025	USD 9.54	-3.63%	Japan
31	Cota Co., Ltd. 31 4923.T	4.65	Jan. 14, 2025	USD 10.09	-0.56%	Japan
32	Daiichi Sankyo Company, Limited 32 4568.T	4.61	Jan. 14, 2025	USD 26.30	0.47%	Japan
33	Terumo Corporation 33 4543.T	4.58	Jan. 14, 2025	USD 18.93	-0.22%	Japan
34	Shionogi & Co., Ltd. 34 4507.T	4.19	Jan. 14, 2025	USD 14.22	-0.40%	Japan
35	Welby Inc. 35 4438.T	4.18	Jan. 14, 2025	USD 2.12	-0.48%	Japan
36	FINDEX Inc. 36 3649.T	3.95	Jan. 14, 2025	USD 5.55	1.55%	Japan
37	JTEC Corporation 37 3446.T	3.92	Jan. 14, 2025	USD 8.49	-1.14%	Japan
38	RaQualia Pharma Inc. 38 4579.T	3.92	Jan. 14, 2025	USD 2.46	-0.69%	Japan
39	M3, Inc. 39 2413.T	3.91	Jan. 14, 2025	USD 9.21	3.00%	Japan
40	ReproCELL Incorporated 40 4978.T	3.90	Jan. 14, 2025	USD 0.66	-1.12%	Japan
41	Sysmex Corporation 41 6869.T	3.82	Jan. 14, 2025	USD 18.62	0.90%	Japan
42	Nagaileben Co., Ltd. 42 7447.T	3.61	Jan. 14, 2025	USD 12.88	-3.23%	Japan
43	CellSource Co., Ltd. 43 4880.T	3.36	Jan. 14, 2025	USD 5.00	-4.99%	Japan
44	Yomeishu Seizo Co., Ltd. 44 2540.T	3.27	Jan. 14, 2025	USD 15.81	-0.26%	Japan
45	Carna Biosciences, Inc. 45 4572.T	2.93	Jan. 14, 2025	USD 1.82	0.52%	Japan
46	Path Corporation 46 3840.T	2.83	Jan. 14, 2025	USD 0.62	-3.15%	Japan
47	3-D Matrix, Ltd. 47 7777.T	2.79	Jan. 14, 2025	USD 0.94	-5.30%	Japan
48	Human Metabolome Technologies, Inc. 48 6090.T	2.75	Jan. 14, 2025	USD 3.90	-1.46%	Japan
49	Nissan Chemical Corporation 49 4021.T	2.70	Jan. 14, 2025	USD 29.83	-1.11%	Japan
50	Olympus Corporation 50 7733.T	2.68	Jan. 14, 2025	USD 14.83	0.94%	Japan

1 2 3 4 5

Frequently Asked Questions

Which Pharmaceuticals company in Japan has the highest Price to Sales Ratio (P/S) ?

The Pharmaceuticals company in Japan with the highest Price to Sales Ratio (P/S) is BrightPath Biotherapeutics Co., Ltd. (Tokyo Stock Exchange: 4594.T) at 48,782.23.
Which Pharmaceuticals company in Japan has the lowest Price to Sales Ratio (P/S) ?

The Pharmaceuticals company in Japan with the lowest Price to Sales Ratio (P/S) is Ohki Healthcare Holdings Co.,Ltd. (Tokyo Stock Exchange: 3417.T) at 0.03.

What are the top 10 Pharmaceuticals companies in Japan by Price to Sales Ratio (P/S) ?

The top 10 Pharmaceuticals companies in Japan by Price to Sales Ratio (P/S) are BrightPath Biotherapeutics Co., Ltd., FunPep Company Limited, Oncolys BioPharma Inc., MedRx Co., Ltd, Kringle Pharma, Inc., Perseus Proteomics Inc., NanoCarrier Co., Ltd., Kubota Pharmaceutical Holdings Co., Ltd., Stella Pharma Corporation and CellSeed Inc..
What are the bottom 10 Pharmaceuticals companies in Japan by Price to Sales Ratio (P/S) ?

The bottom 10 Pharmaceuticals companies in Japan by Price to Sales Ratio (P/S) are Ohki Healthcare Holdings Co.,Ltd., Medius Holdings Co., Ltd., Yamashita Health Care Holdings,Inc., Vital KSK Holdings, Inc., Medical System Network Co., Ltd., Tohoku Chemical Co., Ltd., OLBA HEALTHCARE HOLDINGS, Inc., Pharmarise Holdings Corporation, Satudora Holdings Co.,Ltd. and NIHON CHOUZAI Co.,Ltd..